Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Super House Ltd
NSE:SUPERHOUSE
|
IN |
|
Y
|
Yau Lee Holdings Ltd
HKEX:406
|
HK |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (7.4), the stock would be worth €9.56 (2% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 7.3 | €9.4 |
0%
|
| 3-Year Average | 7.4 | €9.56 |
+2%
|
| 5-Year Average | 8.9 | €11.46 |
+22%
|
| Industry Average | 10.5 | €13.56 |
+44%
|
| Country Average | 7.6 | €9.78 |
+4%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
€226.9m
|
/ |
Jan 2026
€34.8m
|
= |
|
|
€226.9m
|
/ |
Dec 2026
€43.4m
|
= |
|
|
€226.9m
|
/ |
Dec 2027
€48.6m
|
= |
|
|
€226.9m
|
/ |
Dec 2028
€53.2m
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| IT |
|
Fine Foods & Pharmaceuticals NTM SpA
MIL:FF
|
215m EUR | 7.3 | 21.7 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 1 224.1 | 4 272.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
198.1B USD | 20.4 | 29.6 | |
| US |
|
Danaher Corp
NYSE:DHR
|
137.7B USD | 19.4 | 38.1 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 30.1 | 46.1 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.3B CHF | 18 | -133.3 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
296.6B CNY | 16.1 | 15.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
34.5B USD | 19.6 | 26.7 | |
| US |
|
Waters Corp
NYSE:WAT
|
32.2B USD | 32.3 | 50 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.9B USD | 12.2 | 22.1 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
27.3B USD | 23.2 | 31.4 |
Market Distribution
| Min | 0.7 |
| 30th Percentile | 5.2 |
| Median | 7.6 |
| 70th Percentile | 10.8 |
| Max | 3 328.6 |
Other Multiples
Fine Foods & Pharmaceuticals NTM SpA
Glance View
Fine Foods & Pharmaceuticals N.T.M. The company is headquartered in Verdellino, Bergamo and currently employs 768 full-time employees. The company went IPO on 2016-10-19. The company is specialized in the manufacturing of pharmaceutical products for third parties. The firm manages three segments: Pharmaceuticals, Nutraceuticals and Medical Devices. The Pharmaceuticals segment includes powders and granules, tablets, coated tablets and hard gelatin capsules, packaged in sachets, blisters and bottles. The Nutraceuticals segment includes soluble and effervescent powders and granules, soluble, effervescent and chewable tablets, coated tablets and hard gelatin capsules packaged in bags, sachets, sticks, jars, tablet bottles, blisters and strips. The Medical Devices segment includes tablets, capsules, powders, granules and cover the areas for gastrointestinal, oral and throat treatment and the weight management. Medical Devices marked CE (European Conformity) are available for licensing.
